The potential for central monitoring techniques to replace on-site monitoring: Findings from an international multi-centre clinical trial

Clinical Trials

Volumn 9, Issue 2, 2012, Pages 257-264

  Bakobaki, Julie M ^a   Rauchenberger, Mary ^a   Joffe, Nicola ^a   McCormack, Sheena ^a   Stenning, Sally ^a   Meredith, Sarah ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBICIDE; PLACEBO;

AFRICA; ARTICLE; BIBLIOGRAPHIC DATABASE; CENTRAL MONITORING; CLINICAL PROTOCOL; CONTROLLED STUDY; GEL; GOOD CLINICAL PRACTICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; MULTICENTER STUDY; ON SITE MONITORING; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SOUTH AFRICA;

ANTI-INFECTIVE AGENTS, LOCAL; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; DRUG MONITORING; FEMALE; GUIDELINE ADHERENCE; HIV INFECTIONS; HUMANS; INTERNATIONALITY; PRACTICE GUIDELINES AS TOPIC; SOUTH AFRICA;

EID: 84861796027     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774511427325     Document Type: Article

References (19)

1. European Medicines Agency ICH Topic E 6 (R1). Guideline for Good Clinical Practice July 2002 CPMP/ICH/135/95. Available at http://www.ema.europa.eu/docs/ en-GB/document-library/Scientific-guideline/2009/09/WC500002874.pdf
2. Grimes D, Hubacher D, Nanda K, et al. The Good Clinical Practice guideline: A bronze standard for clinical research. Lancet. 2005 ; 366: 172-4
3. Duley L, Antman K, Arena J, et al. Specific barriers to the conduct of randomised trials. Clin Trials. 2008 ; 5: 40-8
4. Yusuf S, Bosch J, Devereaux P, et al. Sensible guidelines for the conduct of large randomised trials. Clin Trials. 2008 ; 5: 38-9
5. Califf R. Clinical trials bureaucracy: Unintended consequences of well-intentioned policy. Clin Trials. 2006 ; 3: 496-502
6. Califf R, Morse M, Wittes J, et al. Toward protecting the safety of participants in clinical trials. Contr Clin Trials. 2003 ; 24 (3). 256-71
7. Califf R, Karnash S, Woodlief L. Developing systems for cost effective auditing of clinical trials. Contr Clin Trials. 1997 ; 18: 651-60
8. Baigent C, Harrell F, Buyse M, Emberson JR, Altman D. Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clin Trials. 2008 ; 5 (1). 49-55
9. Journot V, Pignon JP, Gaultier C, et al. On behalf of the Optimon Collaborative Group. Validation of a risk assessment scale and a risk-adapted monitoring plan for academic clinical research studies-The Pre-Optimon study. Contemp Clin Trials. 2010 ;:
10. Brosteanu O, Houben P, Ihrig K, et al. Risk analysis and risk adapted on-site monitoring in non-commercial clinical trials. Clin Trials. 2009 ; 6: 585-96
11. Kirwan B, Lubsen J, de Brouwer S, et al. ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) investigators. Quality management of a large randomised double-blind multi-centre trial: The ACTION experience. Contemp Clin Trials. 2008 ; 29 (2). 259-69
12. Liénard JL, Quinaux E, Fabre-Guillevin E, et al. European Association for Research in Oncology. Impact of on-site initiation visits on patient recruitment and data quality in a randomised trial of adjuvant chemotherapy for breast cancer. Clin Trials. 2006 ; 3 (5). 486-92
13. Williams G. The other side of clinical trial monitoring; assuring data quality and procedural adherence. Clin Trials. 2006 ; 3 (6). 530-7
14. Sather M, Raisch D, Haakenson C, Beckelew J, Feussner J. Promoting good clinical practices in the conduct of clinical trials: Experiences in the Department of Veterans Affairs Cooperative Studies Program. Contr Clin Trials. 2003 ; 24 (5). 570-84
15. Cassel G, Ferris F. Site visits in a multicentre ophthalmic clinical trial. Contr Clin Trials. 1984 ; 5 (3). 251-62
16. Gassman J, Owen W, Kunts T, Martin J, Amoroso W. Data quality assurance, monitoring and reporting. Contr Clin Trials. 1995 ; 16 (2 suppl). 104-36
17. Poortmans P, Ataman F, Davis J, et al. Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: Comparison of the results of two individual case reviews performed early and late during the accrual period. Radiother Oncol. 2005 ; 76 (3). 278-84
18. Nunn A, McCormack S, Crook A, et al. Microbicides Development Programme: Design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials. 2009 ; 10: 99
19. McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): A phase 3, randomised, double-blind, parallel group trial. Lancet. 2010 ; 376: 1329-37